In order to clarify the effect of ESRP1 on prognosis of ovarian cancer patients, we screened TCGA ovarian cancer samples [16], stage III and IV, absence of macroscopic disease after tumor cytoreductive surgery. This evidence concerns the gene ESRP1 and neoplasm.